ticker
Login
business news
Politics And Regulation
Markets
The Economy
Editor's Pick
trading and investing
Stocks
ETFs
Fixed Income
Earnings
Currencies
Commodities
Options
Taxes
Personal Finance
How To Trade
How To Invest
sectors
Biotech/pharma
Consumer
Energy
Financial
Global Markets
Media
Precious Metals
Real Estate
Technology
Transportation
special features
Wall Of Worry
Random Thoughts
Sports Business
Minyanville Press
Video
Hoofy & Boo
Radio
MV PREMIUM
subscriptions
Launch Buzz And Banter
Buzz And Banter
Elliott Wave Insider
Tchir's Fixed Income Report
Cooper's Market Report
Techstrat Report
Optionsmith
The Stock Playbook
Ad Free Minyanville
Minyanville Book Store
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
GlaxoSmithKline PLC ADS
(NY:
GSK
)
52.22
USD
+0.11 (+0.21%)
Official Closing Price
/ Updated:
6:40 PM EDT, May 17, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Blog posts about GlaxoSmithKline PLC ADS
< Previous
1
2
3
4
5
6
7
8
9
...
37
38
Next >
Cheerleaders: Look Beyond Pharma For Jobs
May 16, 2013
category
AZN
,
ABBV
,
TSPT
, and 5 more.
from
YCharts
(GSK) GlaxoSmithKline’s Trametinib Delayed
May 16, 2013
Recently, GlaxoSmithKline (GSK) announced that the US Food and Drug Administration (FDA) has... Visit StockBlogHub to view complete post.
Read More
category
Glaxosmithkline plc
,
Athersys Inc
,
Healthcare
, and 5 more.
from
Stock Blog Hub
(IPXL) Impax Laboratories Beats Earnings Estimate
May 15, 2013
Impax Laboratories Inc.’s (IPXL) first quarter 2013 adjusted earnings of 37 cents per share were... Visit StockBlogHub to view complete post.
Read More
category
Glaxosmithkline plc
,
Transcept Pharmaceuticals Inc
,
CPRX
, and 7 more.
from
Stock Blog Hub
Biotech Drug Royalty Deal
May 14, 2013
Elan Corporation's (NYSE: ELN) has worked to soothe investor concern, and it's also added drug royalties to the company's assets...
Read More
from
Wealth Daily
GlaxoSmithKline Is Near a Key Resistance Area
May 14, 2013
New York, May 14th (TradersHuddle.com) - Shares of GlaxoSmithKline plc ( NYSE:GSK ) are trading very close to calculated resistance at $52.54. The stock ended the trading session at just $51.67, which...
Read More
from
TradersHuddle.com
“Marketing Without Innovation”: a Merck Story
May 10, 2013
category
AZN
,
MRK
,
GSK
, and 3 more.
from
YCharts
Pharma’s Failure: Drug Spending Finally Declines
May 09, 2013
category
AZN
,
MRK
,
GSK
, and 3 more.
from
YCharts
Trading Idea: - Is GlaxoSmithKline close to Resistance?
May 07, 2013
New York, May 7th (TradersHuddle.com) - Shares of GlaxoSmithKline plc ( NYSE:GSK ) are trading very close to calculated resistance at $52.54. The stock ended the trading session at just $51.02, which...
Read More
from
TradersHuddle.com
News Recap: NII Holdings, Companhia Siderurgica Nacional, JDS Uniphase Corp, GlaxoSmithKline Plc
May 01, 2013
Austin, TX -- (SBWIRE) -- 05/01/2013 -- Jackpotpennystocks.com, an investor research portal specializing in several sectors including biotech and healthcare and tech stocks on the U.S. market, issues...
Read More
from
SBWire - Latest Press Releases
GlaxoSmithKline Is Moving Above Resistance
April 30, 2013
New York, April 30th (TradersHuddle.com) - Shares of GlaxoSmithKline plc ( NYSE:GSK ) closed the session at $52.42 just above calculated resistance at $52.30. The stock moved to what appears to be a...
Read More
from
TradersHuddle.com
Merck Seeks Boost For $4B-a-Year Diabetes Drug
April 29, 2013
category
AZN
,
MRK
,
GSK
, and 3 more.
from
YCharts
GlaxoSmithKline Is Near a Key Resistance Area
April 29, 2013
New York, April 29th (TradersHuddle.com) - Shares of GlaxoSmithKline plc ( NYSE:GSK ) are trading very close to calculated resistance at $52.30. The stock ended the trading session at just $52.16,...
Read More
from
TradersHuddle.com
(NVS) Theravance – Glaxo Drug to Face FDA Panel
April 27, 2013
The US Food and Drug Administration (FDA) recently released briefing documents ahead of the review... Visit StockBlogHub to view complete post.
Read More
category
Glaxosmithkline plc
,
THRX
,
CELG
, and 7 more.
from
Stock Blog Hub
Key Pfizer Drug in Trouble In Europe
April 26, 2013
category
ABBV
,
MRK
,
GSK
, and 3 more.
from
YCharts
GlaxoSmithKline Is Moving Above Resistance
April 25, 2013
New York, April 25th (TradersHuddle.com) - Shares of GlaxoSmithKline plc ( NYSE:GSK ) closed the session at $51.35 just above calculated resistance at $50.95. The stock effectively broke out and...
Read More
from
TradersHuddle.com
Another Reason the Pharma Pipeline is Lacking
April 23, 2013
category
AZN
,
MRK
,
GSK
, and 3 more.
from
YCharts
GlaxoSmithKline Is Near a Key Resistance Area
April 23, 2013
New York, April 23rd (TradersHuddle.com) - Shares of GlaxoSmithKline plc ( NYSE:GSK ) are trading very close to calculated resistance at $50.95. The stock ended the trading session at just $50.44,...
Read More
from
TradersHuddle.com
My Best 4 Most Unpredictable Inventory for Lengthy Time : ADS, UNXL, EXAS, GSK
April 19, 2013
New York, NY -- (SBWIRE) -- 04/19/2013 -- Alliance Data Systems Corp. (NYSE: ADS) reported Q1 EPS of $2.55, $0.04 better than the analyst estimate of $2.51. Revenue for the quarter came in at $1.05...
Read More
from
SBWire - Latest Press Releases
(GSK) GlaxoSmithKline’s Flu Vaccine Approved
April 18, 2013
GlaxoSmithKline(GSK) recently announced the receipt of marketing authorization for its four-strain... Visit StockBlogHub to view complete post.
Read More
category
Glaxosmithkline plc
,
Sanofi/Aventis
,
Charles River Laboratories International Inc
, and 7 more.
from
Stock Blog Hub
Above Resistance: GlaxoSmithKline
April 18, 2013
New York, April 18th (TradersHuddle.com) - Shares of GlaxoSmithKline plc ( NYSE:GSK ) closed the session at $50.34 just above calculated resistance at $50.16. The stock moved to what appears to be a...
Read More
from
TradersHuddle.com
GlaxoSmithKline Is Near Resistance
April 17, 2013
New York, April 17th (TradersHuddle.com) - Shares of GlaxoSmithKline plc ( NYSE:GSK ) are trading very close to calculated resistance at $50.16. The stock ended the trading session at just $49.38,...
Read More
from
TradersHuddle.com
Investors Buzz: Concur Technologies, GlaxoSmithKline, Lamar Advertising, Trina Solar
April 16, 2013
Dallas, TX -- (SBWIRE) -- 04/16/2013 -- Marketbuzzreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the...
Read More
from
SBWire - Latest Press Releases
Big Prints In Bearish Options On XLF
April 12, 2013
Today’s tickers: XLF, GSK & M XLF - Financial Select Sector SPDR ETF – Shares in the XLF are in negative territory this morning, down 0.90% at $18.39 as of 11:10 a.m. ET, amid broad-based declines in...
Read More
category
M
,
GSK
,
XLF
, and 1 more.
from
Phil’s Stock World
Stocks in Spotlight: Wal-Mart Stores, GlaxoSmithKline Plc, Regions Financial Corporation, Keryx Biopharmaceuticals
April 11, 2013
Dallas, TX -- (SBWIRE) -- 04/11/2013 -- Marketbuzzreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the...
Read More
from
SBWire - Latest Press Releases
Stocks Recap: Metlife Inc, GlaxoSmithKline Plc, Time Warner Inc, Teck Resources Ltd
April 09, 2013
Lakeway, TX -- (SBWIRE) -- 04/09/2013 -- vbtrendreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the...
Read More
from
SBWire - Latest Press Releases
GlaxoSmithKline Is Moving Above Resistance
April 09, 2013
New York, April 9th (TradersHuddle.com) - Shares of GlaxoSmithKline plc ( NYSE:GSK ) closed the session at $47.07 just above calculated resistance at $46.68. The stock moved to what appears to be a...
Read More
from
TradersHuddle.com
GlaxoSmithKline Is Near Important Moving Averages
April 08, 2013
New York, April 8th (TradersHuddle.com) - Shares of GlaxoSmithKline plc ( NYSE:GSK ) closed the session at $46.79, near the 50 day and 200 day moving averages currently set at $45.41 and $45.21...
Read More
from
TradersHuddle.com
(MRK) Pharma & Biotech Stock Outlook – Apr 2013 – Zacks Analyst Interviews
April 07, 2013
The pharmaceutical industry has been showing signs of recovery from one of the biggest patent... Visit StockBlogHub to view complete post.
Read More
category
Mylan Inc/
,
Glaxosmithkline plc
,
TEVA
, and 47 more.
from
Stock Blog Hub
GlaxoSmithKline Broke Resistance
April 03, 2013
New York, April 3rd (TradersHuddle.com) - Shares of GlaxoSmithKline plc ( NYSE:GSK ) closed the session at $46.97 just above calculated resistance at $46.68. The stock effectively broke out and grasped...
Read More
from
TradersHuddle.com
GlaxoSmithKline Broke Resistance
March 29, 2013
New York, March 29th (TradersHuddle.com) - Shares of GlaxoSmithKline plc ( NYSE:GSK ) closed the session at $46.91 just above calculated resistance at $46.68. The stock effectively broke out and...
Read More
from
TradersHuddle.com
< Previous
1
2
3
4
5
6
7
8
9
...
37
38
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Stay Connected
WHAT'S POPULAR IN THE VILLE
1
1929, 1987, and 2013: Three of a Kind?
Jeffrey Cooper
2
The Top 5 Spookiest Technologies
Nick Shchetko
3
The Tesla Model S Is the New Toyota Prius
Michael Comeau
4
Black Swan Watch: Mexico's Super Volcano Could Be the Next Market Catalyst
Duncan Parker
5
BlackBerry: Why Expanding BBM to iOS and Android Is Smart -- and Hazardous
Sterling Wong
See All Articles
»
Financial Product Guide